| Efficacy of large doses of IL-2-activated human leukocyte antigen ... - UroToday |
|
|
UroToday Traditional immunotherapy for patients with refractory metastatic renal cell carcinoma (RCC) is limited because the tumors themselves induce immunosuppression. The aim of this article was to evaluate the clinical efficacy of the infusion of a high dose |